Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 75

1.

Docking studies towards exploring antiviral compounds against envelope protein of yellow fever virus.

Umamaheswari A, Kumar MM, Pradhan D, Marisetty H.

Interdiscip Sci. 2011 Mar;3(1):64-77. doi: 10.1007/s12539-011-0064-y. Epub 2011 Mar 3.

PMID:
21369890
[PubMed - indexed for MEDLINE]
2.

In silico screening of small molecule libraries using the dengue virus envelope E protein has identified compounds with antiviral activity against multiple flaviviruses.

Kampmann T, Yennamalli R, Campbell P, Stoermer MJ, Fairlie DP, Kobe B, Young PR.

Antiviral Res. 2009 Dec;84(3):234-41. doi: 10.1016/j.antiviral.2009.09.007. Epub 2009 Sep 23.

PMID:
19781577
[PubMed - indexed for MEDLINE]
3.

Antiviral compounds discovered by virtual screening of small-molecule libraries against dengue virus E protein.

Zhou Z, Khaliq M, Suk JE, Patkar C, Li L, Kuhn RJ, Post CB.

ACS Chem Biol. 2008 Dec 19;3(12):765-75. doi: 10.1021/cb800176t.

PMID:
19053243
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Molecular basis for attenuation of neurovirulence of a yellow fever Virus/Japanese encephalitis virus chimera vaccine (ChimeriVax-JE).

Arroyo J, Guirakhoo F, Fenner S, Zhang ZX, Monath TP, Chambers TJ.

J Virol. 2001 Jan;75(2):934-42.

PMID:
11134306
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Identification of a dominant endoplasmic reticulum-retention signal in yellow fever virus pre-membrane protein.

Ciczora Y, Callens N, Séron K, Rouillé Y, Dubuisson J.

J Gen Virol. 2010 Feb;91(Pt 2):404-14. doi: 10.1099/vir.0.015339-0. Epub 2009 Oct 21.

PMID:
19846669
[PubMed - indexed for MEDLINE]
Free Article
6.

Identification of novel target sites and an inhibitor of the dengue virus E protein.

Yennamalli R, Subbarao N, Kampmann T, McGeary RP, Young PR, Kobe B.

J Comput Aided Mol Des. 2009 Jun;23(6):333-41. doi: 10.1007/s10822-009-9263-6. Epub 2009 Feb 25.

PMID:
19241120
[PubMed - indexed for MEDLINE]
7.

Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus.

Bonaldo MC, Garratt RC, Caufour PS, Freire MS, Rodrigues MM, Nussenzweig RS, Galler R.

J Mol Biol. 2002 Jan 25;315(4):873-85.

PMID:
11812154
[PubMed - indexed for MEDLINE]
8.

The 15 amino acid residues preceding the amino terminus of the envelope protein in the yellow fever virus polyprotein precursor act as a signal peptide.

Desprès P, Ruiz-Linarès A, Cahour A, Girard M, Wychowski C, Bouloy M.

Virus Res. 1990 Apr;16(1):59-75.

PMID:
2161594
[PubMed - indexed for MEDLINE]
9.

Structure of yellow fever virus envelope protein domain III.

Volk DE, May FJ, Gandham SH, Anderson A, Von Lindern JJ, Beasley DW, Barrett AD, Gorenstein DG.

Virology. 2009 Nov 10;394(1):12-8. doi: 10.1016/j.virol.2009.09.001. Epub 2009 Oct 8.

PMID:
19818466
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Design, synthesis, and biological evaluation of thiazoles targeting flavivirus envelope proteins.

Mayhoub AS, Khaliq M, Kuhn RJ, Cushman M.

J Med Chem. 2011 Mar 24;54(6):1704-14. doi: 10.1021/jm1013538. Epub 2011 Feb 28.

PMID:
21355607
[PubMed - indexed for MEDLINE]
11.

Yellow fever 17D virus: pseudo-revertant suppression of defective virus penetration and spread by mutations in domains II and III of the E protein.

Vlaycheva L, Nickells M, Droll DA, Chambers TJ.

Virology. 2004 Sep 15;327(1):41-9.

PMID:
15327896
[PubMed - indexed for MEDLINE]
12.

A small-molecule dengue virus entry inhibitor.

Wang QY, Patel SJ, Vangrevelinghe E, Xu HY, Rao R, Jaber D, Schul W, Gu F, Heudi O, Ma NL, Poh MK, Phong WY, Keller TH, Jacoby E, Vasudevan SG.

Antimicrob Agents Chemother. 2009 May;53(5):1823-31. doi: 10.1128/AAC.01148-08. Epub 2009 Feb 17.

PMID:
19223625
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Neuroadapted yellow fever virus strain 17D: a charged locus in domain III of the E protein governs heparin binding activity and neuroinvasiveness in the SCID mouse model.

Nickells J, Cannella M, Droll DA, Liang Y, Wold WS, Chambers TJ.

J Virol. 2008 Dec;82(24):12510-9. doi: 10.1128/JVI.00458-08. Epub 2008 Oct 8.

PMID:
18842715
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Functional requirements of the yellow fever virus capsid protein.

Patkar CG, Jones CT, Chang YH, Warrier R, Kuhn RJ.

J Virol. 2007 Jun;81(12):6471-81. Erratum in: J Virol. 2007 Dec;81(24):13944.

PMID:
17526891
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Comparative phylogenies of yellow fever isolates from Peru and Brazil.

Bryant JE, Barrett AD.

FEMS Immunol Med Microbiol. 2003 Nov 28;39(2):103-18.

PMID:
14625093
[PubMed - indexed for MEDLINE]
16.

Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice.

van der Most RG, Harrington LE, Giuggio V, Mahar PL, Ahmed R.

Virology. 2002 Apr 25;296(1):117-24.

PMID:
12036323
[PubMed - indexed for MEDLINE]
17.

RNA interference inhibits yellow fever virus replication in vitro and in vivo.

Pacca CC, Severino AA, Mondini A, Rahal P, D'avila SG, Cordeiro JA, Nogueira MC, Bronzoni RV, Nogueira ML.

Virus Genes. 2009 Apr;38(2):224-31. doi: 10.1007/s11262-009-0328-3. Epub 2009 Jan 25.

PMID:
19169857
[PubMed - indexed for MEDLINE]
18.

Phenotypic and molecular characterization of a non-lethal, hamster-viscerotropic strain of yellow fever virus.

McArthur MA, Xiao SY, Barrett AD.

Virus Res. 2005 Jun;110(1-2):65-71.

PMID:
15845256
[PubMed - indexed for MEDLINE]
19.

Expression of the yellow fever virus envelope protein using hybrid SV40/yellow fever viruses.

Desprès P, Cahour A, Wychowski C, Girard M, Bouloy M.

Ann Inst Pasteur Virol. 1988 Jan-Mar;139(1):59-67.

PMID:
3061412
[PubMed - indexed for MEDLINE]
20.

Identification of structural motifs in the E2 glycoprotein of Chikungunya involved in virus-host interaction.

Asnet Mary J, Paramasivan R, Tyagi BK, Surender M, Shenbagarathai R.

J Biomol Struct Dyn. 2013 Oct;31(10):1077-85. doi: 10.1080/07391102.2012.721496. Epub 2012 Oct 2.

PMID:
23025271
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk